Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2004

View Archived Issues

Sepracor highlights year-end 2003 progress

T-0901317 induces severe lipogenesis in diabetic mice

Novel selective cytokine inhibitory drugs demonstrate enhanced antiangiogenic activity

Novel protease inhibitor SM-322377 active against multidrug-resistant HIV variants

Cleveland Clinic and Ricerca to develop cobalamin-based anticancer compound

SU-11248 inhibits tumor growth and osteolysis in a human breast cancer bone metastasis model

Altana researchers present two novel series of PARP-1 inhibitors

Procter & Gamble claims ICE inhibitors for bone disorders and other uses

GSK scientists identify new cathepsin K/falcipain inhibitors

Takeda patent covers novel tachykinin antagonists with utility in urinary disorders

New antitumor agents developed by RIKEN scientists

NO-containing COX-2 inhibitors in early development at NitroMed

Glycine transport inhibitors from bacterial source and their use in ataxia

Merck and Jerini to develop small molecule inhibitors for cancer

Tanabe gains Japanese rights to prasterone

Pfizer submits sNDA for Geodon product label changes

NeoRx receives payment from Boston Scientific

Rapid absorption, high plasma concentrations in phase I nasal fentanyl study

Activa Therapy more effective than pallidotomy in Parkinson's patients

Betaseron prefilled diluent syringe launched in U.S.

Phase III Thymitaq trial cleared to continue by DSMB

Lilly reacts to opinion paper on antipsychotic drugs in obesity and diabetes

Initial proof-of-concept study successfully completed for Provasca

Rigel reports on the progress of R-803, R-406

European orphan drug status for sildenafil for PAH

Provectus prepares IND filing for Provecta

Launch of Zoderm acne treatment

Xcytrin enters phase I trial in combination with Temodar for glioma

Viral Therapeutics acquires development rights to Virusorb

Lipid profile improvements found with D-003 in patients with type II hypercholesterolemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...